Mary Pawelek has more than 20 years of experience in product liability litigation and focuses her practice on defending global pharmaceutical manufacturers in mass tort litigation and individual matters. Mary currently serves as national coordinating counsel on corporate liability and scientific issues in a nationwide pharmaceutical mass tort and as monitoring counsel in another. In two other large-scale pharmaceutical mass torts, she serves as national counsel for sales representatives and in one she also has national responsibility for company documents.
Mary has extensive experience in the organization and administration of pharmaceutical mass tort litigation, particularly in developing corporate defense strategies and evaluating complex medical, legal, and scientific matters including discovery issues. She also has worked with clients on litigation risk assessments and management strategy. Mary has handled numerous pharmaceutical cases through dispositive pre-trial motions and has negotiated non-suits. Throughout her career, she has worked on many discovery and document production issues and has prepared and defended company witnesses in the areas of drug safety, regulatory, medical/scientific affairs and marketing, including sales representatives. Mary has also been a member of several high profile trials.
Mary joined Bowman and Brooke in 2011 to establish the firm’s second Texas office in Austin, and is a member of the firm's six-person Executive Committee.